Name: UMIN ID:
Unique ID issued by UMIN | UMIN000006078 |
---|---|
Receipt number | R000007192 |
Scientific Title | A phase II study of Erlotinib as 2nd-line treatment for patients with StageIIIB/IV non-small cell lung cancer |
Date of disclosure of the study information | 2011/07/30 |
Last modified on | 2018/02/19 15:12:50 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/07/29 22:03:36 | ||
2 | Update | 2018/02/19 15:12:50 | Recruitment status |